US Bankruptcy Court for the District of Delaware
Case #: 17-10570
Processing court docket...
| Date | Docket No.No. | Docket Text |
|---|---|---|
| 9/15/2017 | 547 | Findings of Fact, Conclusions of Law, and Order Confirming Debtors' Combined Plan and Disclosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. (related document(s)449, 511) Signed on 9/15/2017. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2) (LCN) (Entered: 09/15/2017) Email |
| 9/12/2017 | 537 | Declaration of James Patrick Carroll, Chief Restructuring Officer, In Support of Confirmation of Debtors' Combined Plan and Disclosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. (related document(s)449) Filed by Bostwick Laboratories, Inc.. (Meltzer, Evelyn) (Entered: 09/12/2017) Email |
| 9/6/2017 | 524 | Declaration of Jung W. Song on Behalf of Donlin Recano & Company, Inc. Regarding Voting and Tabulation of Ballots Accepting and Rejecting Debtors' Combined Plan and Dislcosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. Filed by Bostwick Laboratories, Inc.. (Schanne, John) (Entered: 09/06/2017) Email |
| 8/25/2017 | 511 | Affidavit / Notice of Filing of Amended Causes of Action List as Exhibit A to Combined Plan and Disclosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. (related document(s)449) Filed by Bostwick Laboratories, Inc.. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2) (Meltzer, Evelyn) (Entered: 08/25/2017) Email |
| 8/1/2017 | 450 | Exhibit(s) / Notice of Filing of Blackline regarding Combined Plan and Disclosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. (related document(s)383, 449) Filed by Bostwick Laboratories, Inc.. (Attachments: # 1 Exhibit A) (Meltzer, Evelyn) (Entered: 08/01/2017) Email |
| 8/1/2017 | 449 | Amended Chapter 11 Plan / Debtors' Combined Plan and Disclosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. (related document(s)383) Filed by Bostwick Laboratories, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Meltzer, Evelyn) (Entered: 08/01/2017) Email |
| 8/1/2017 | 446 | Order (A) Approving Combined Plan and Disclosure Statement on a Preliminary Basis, (B) Scheduling Combined Hearing on Approval and Confirmation of Combined Plan and Disclosure Statement, (C) Establishing Procedures for Solicitation and Tabulation of Votes on Combined Plan and Disclosure Statement, and (D) Approving Related Matters. (related document(s)383) Signed on 8/1/2017. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Exhibit D # 5 Exhibit E) (LCN) (Entered: 08/01/2017) Email |
| 7/11/2017 | 383 | Chapter 11 Plan of Reorganization / Debtors' Combined Plan and Disclosure Statement for Bostwick Laboratories, Inc. and Bostwick Laboratories Holdings, Inc. Filed by Bostwick Laboratories, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Meltzer, Evelyn) (Entered: 07/11/2017) Email |